These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10997395)

  • 1. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate.
    Devito C; Hinkula J; Kaul R; Lopalco L; Bwayo JJ; Plummer F; Clerici M; Broliden K
    AIDS; 2000 Sep; 14(13):1917-20. PubMed ID: 10997395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.
    Devito C; Hinkula J; Kaul R; Kimani J; Kiama P; Lopalco L; Barass C; Piconi S; Trabattoni D; Bwayo JJ; Plummer F; Clerici M; Broliden K
    J Acquir Immune Defic Syndr; 2002 Aug; 30(4):413-20. PubMed ID: 12138348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis.
    Tudor D; Derrien M; Diomede L; Drillet AS; Houimel M; Moog C; Reynes JM; Lopalco L; Bomsel M
    Mucosal Immunol; 2009 Sep; 2(5):412-26. PubMed ID: 19587640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers.
    Broliden K; Hinkula J; Devito C; Kiama P; Kimani J; Trabbatoni D; Bwayo JJ; Clerici M; Plummer F; Kaul R
    Immunol Lett; 2001 Nov; 79(1-2):29-36. PubMed ID: 11595287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells.
    Devito C; Broliden K; Kaul R; Svensson L; Johansen K; Kiama P; Kimani J; Lopalco L; Piconi S; Bwayo JJ; Plummer F; Clerici M; Hinkula J
    J Immunol; 2000 Nov; 165(9):5170-6. PubMed ID: 11046049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and mucosal fluid from HIV type 1-infected patients but not from HIV type 1-exposed uninfected subjects prevent HIV type 1-exposed DC from infecting other target cells.
    Söderlund J; Hirbod T; Smed-Sörensen A; Johansson U; Kimani J; Plummer F; Spetz AL; Andersson J; Kaul R; Broliden K
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):101-6. PubMed ID: 17263639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples.
    Choi RY; Levinson P; Guthrie BL; Lohman-Payne B; Bosire R; Liu AY; Hirbod T; Kiarie J; Overbaugh J; John-Stewart G; Broliden K; Farquhar C
    AIDS; 2012 Nov; 26(17):2155-63. PubMed ID: 22948273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group.
    Beyrer C; Artenstein AW; Rugpao S; Stephens H; VanCott TC; Robb ML; Rinkaew M; Birx DL; Khamboonruang C; Zimmerman PA; Nelson KE; Natpratan C
    J Infect Dis; 1999 Jan; 179(1):59-67. PubMed ID: 9841823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunoglobulin A in HIV-exposed seronegative individuals.
    Trabattoni D; Biasin M; Clerici M
    AIDS; 2012 Nov; 26(17):2247-50. PubMed ID: 23123517
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV-1 neutralizing activity is correlated with increased levels of chemokines in saliva of HIV-1-exposed uninfected individuals.
    Hirbod T; Reichard C; Hasselrot K; Söderlund J; Kimani J; Bwayo JJ; Plummer F; Kaul R; Broliden K
    Curr HIV Res; 2008 Jan; 6(1):28-33. PubMed ID: 18288972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
    Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
    New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.
    Mazzoli S; Lopalco L; Salvi A; Trabattoni D; Lo Caputo S; Semplici F; Biasin M; Bl C; Cosma A; Pastori C; Meacci F; Mazzotta F; Villa ML; Siccardi AG; Clerici M
    J Infect Dis; 1999 Sep; 180(3):871-5. PubMed ID: 10438383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers.
    Kaul R; Trabattoni D; Bwayo JJ; Arienti D; Zagliani A; Mwangi FM; Kariuki C; Ngugi EN; MacDonald KS; Ball TB; Clerici M; Plummer FA
    AIDS; 1999 Jan; 13(1):23-9. PubMed ID: 10207541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.
    Bélec L; Ghys PD; Hocini H; Nkengasong JN; Tranchot-Diallo J; Diallo MO; Ettiègne-Traore V; Maurice C; Becquart P; Matta M; Si-Mohamed A; Chomont N; Coulibaly IM; Wiktor SZ; Kazatchkine MD
    J Infect Dis; 2001 Dec; 184(11):1412-22. PubMed ID: 11709783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tropism-restricted neutralization by secretory IgA from parotid saliva of HIV type 1-infected individuals.
    Wu X; Hall S; Jackson S
    AIDS Res Hum Retroviruses; 2003 Apr; 19(4):275-81. PubMed ID: 12804003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing antibodies in mucosal secretions: IgG or IgA?
    Alexander R; Mestecky J
    Curr HIV Res; 2007 Nov; 5(6):588-93. PubMed ID: 18045115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers.
    Hirbod T; Kaul R; Reichard C; Kimani J; Ngugi E; Bwayo JJ; Nagelkerke N; Hasselrot K; Li B; Moses S; ; MacDonald KS; Broliden K
    AIDS; 2008 Mar; 22(6):727-35. PubMed ID: 18356602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory IgA specific for MPER can protect from HIV-1 infection in vitro.
    Benjelloun F; Dawood R; Urcuqui-Inchima S; Rochereau N; Chanut B; Verrier B; Lucht F; Genin C; Paul S
    AIDS; 2013 Jul; 27(12):1992-5. PubMed ID: 23696073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals.
    Lü FX
    Clin Immunol; 2000 Oct; 97(1):59-68. PubMed ID: 10998318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
    Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
    J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.